All Stories

  1. The Real-World Endocrine Toxicity Profile of ICIs, VEGFR-TKIs, and Their Combination: Analysis of the FDA Adverse Event Reporting System (FAERS) Database

    Article • Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, January 2026, Tsinghua University Press

    Professor Francesco Giorgino

  2. Serum Homocysteine Levels in Men with and without Erectile Dysfunction: A Systematic Review and Meta-Analysis

    Article • International Journal of Endocrinology, August 2018, Hindawi Publishing Corporation

    Professor Andrea M. Isidori, Professor Francesco Giorgino, Angelo Cignarelli

  3. Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement

    Article • Patient Preference and Adherence, May 2018, Dove Medical Press

    Professor Francesco Giorgino

  4. GLP-1 Receptor Activation Inhibits Palmitate-Induced Apoptosis via Ceramide in Human Cardiac Progenitor Cells

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2017, Endocrine Society

    Professor Francesco Giorgino, Angelo Cignarelli

  5. The Myokine Irisin Is Released in Response to Saturated Fatty Acids and Promotes Pancreatic β-Cell Survival and Insulin Secretion

    Article • Diabetes, July 2017, American Diabetes Association

    Professor Francesco Giorgino

  6. Effects of Structured Versus Unstructured Self-Monitoring of Blood Glucose on Glucose Control in Patients With Non-insulin-treated Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials

    Article • Journal of Diabetes Science and Technology, July 2017, SAGE Publications

    Professor Francesco Giorgino, Edoardo Mannucci

  7. Ubiquitination and diabetic nephropathy

    Article • The FASEB Journal, October 2016, Federation of American Societies For Experimental Biology (FASEB)

    Massimo Papale, Dr Salvatore Di Paolo, Giuseppe Grandaliano, PhD Paola Pontrelli, Professor Francesco Giorgino

  8. Treatment intensification in patients with inadequate glycemic control on basal insulin: rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonists

    Article • Diabetes/Metabolism Research and Reviews, March 2016, Wiley

    Professor Francesco Giorgino